| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 743.467 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 751.048 | 94 |
| GSM780709 | Untreated after 4 days (C3_1) | 727.427 | 94 |
| GSM780719 | Untreated after 4 days (C1_2) | 656.776 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 794.487 | 94 |
| GSM780721 | Untreated after 4 days (C3_2) | 692.227 | 94 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 735.877 | 94 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 703.887 | 94 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 706.83 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 708.389 | 94 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 613.732 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 623.538 | 93 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 641.954 | 93 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 752.5 | 94 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 633.791 | 93 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 528.369 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 726.952 | 94 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 642.982 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 543.7 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 637.13 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 719.649 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 523.503 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 658.678 | 93 |